Lynne L Johnson Selected Research

Technetium Tc 99m Pyrophosphate

1/2022	The importance of SPECT cardiac reconstruction for accurate 99mTc-pyrophosphate interpretation in TTR amyloidosis.
1/2021	Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynne L Johnson Research Topics

Disease

6	Atherosclerotic Plaque (Atheroma) 01/2018 - 11/2008
5	Atherosclerosis 01/2018 - 11/2008
4	Fibrosis (Cirrhosis) 01/2021 - 02/2003
3	Peripheral Arterial Disease 01/2021 - 12/2018
3	Ischemia 05/2020 - 06/2015
3	Inflammation (Inflammations) 01/2018 - 05/2010
3	Infarction (Infarctions) 06/2013 - 11/2004
2	Amyloidosis 01/2022 - 01/2021
2	Emphysema 06/2019 - 12/2016
2	Myocardial Infarction 06/2013 - 02/2006
2	Reperfusion Injury 01/2012 - 11/2004
1	Hypoxia (Hypoxemia) 06/2013
1	Myocardial Reperfusion Injury 01/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012
1	Familial Primary Pulmonary Hypertension 11/2011
1	Right Ventricular Dysfunction 11/2011
1	Thrombosis (Thrombus) 05/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2010
1	Diabetes Mellitus 01/2010
1	Death (Near-Death Experience) 02/2006
1	Atrioventricular Block 11/2005
1	End Stage Liver Disease 11/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2005
1	Coronary Occlusion 11/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2004
1	Vascular Diseases (Vascular Disease) 02/2004
1	Pathologic Constriction (Stenosis) 02/2004

Drug/Important Bio-Agent (IBA)

5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 11/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2014
4	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2020 - 12/2014
2	Technetium Tc 99m PyrophosphateIBA 01/2022 - 01/2021
2	SmokeIBA 06/2019 - 12/2016
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018 - 12/2014
2	ApolipoproteinsIBA 01/2014 - 01/2010
2	Annexin A5IBA 06/2013 - 12/2010
2	FibrinIBA 06/2013 - 05/2010
2	Advanced Glycation End ProductsIBA 01/2012 - 01/2010
2	LigandsIBA 01/2012 - 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	Prealbumin (Transthyretin)IBA 01/2021
1	n-dodecaneIBA 01/2021
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2021
1	IntegrinsIBA 12/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	IsotopesIBA 06/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2013
1	CaspasesIBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Matrix Metalloproteinase InhibitorsIBA 12/2010
1	Matrix Metalloproteinases (MMPs)IBA 12/2010
1	Retinaldehyde (Retinal)IBA 02/2010
1	Streptozocin (Streptozotocin)FDA Link 01/2010
1	Biological ProductsIBA 01/2010
1	Monoclonal AntibodiesIBA 01/2010
1	LectinsIBA 07/2008
1	Vasodilator Agents (Vasodilators)IBA 02/2006
1	Adenosine (Adenocard)FDA LinkGeneric 11/2005
1	Aminophylline (Carine)FDA LinkGeneric 11/2005
1	Technetium (Technetium 99m)IBA 07/2005
1	Peroxidase (Myeloperoxidase)IBA 11/2004
1	Oxygen (Dioxygen)IBA 11/2004
1	SolutionsIBA 11/2004
1	Radioisotopes (Radionuclides)IBA 05/2004
1	AntibodiesIBA 02/2004
1	PolymersIBA 02/2004
1	Bromodeoxyuridine (BrdU)IBA 02/2004
1	ameroidIBA 02/2003
1	ThalliumIBA 02/2003
1	Dobutamine FDA LinkGeneric 02/2003

Therapy/Procedure

1	Therapeutics 05/2020
1	Contraindications 02/2006
1	Liver Transplantation 11/2005
1	Catheters 02/2003